XORTX Therapeutics Inc (TSE:XRTX) has released an update.
XORTX Therapeutics Inc., a pharmaceutical company specializing in kidney disease treatments, is set to present at the BIO International Convention 2024. The company’s CEO, Dr. Allen Davidoff, will discuss XORTX’s current progress and future plans for regulatory and clinical activities. This marks an important industry outreach opportunity, with over 25 meetings arranged to engage with potential partners.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
